跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18,573 条关于
“ATI-052”
全部
18,573
临床试验
9,790
药物
4,488
机构
118
资讯
4,177
8个月前
Aclaris Therapeutics Reports Positive Phase 1a Results for Bispecific Antibody ATI-052, Accelerating Development Timeline
2年前
NIDA Funds Small Businesses to Develop Decentralized Clinical Trial Tools for Substance Use Disorders
去年
Appili Therapeutics Advances ATI-1801 Development for Cutaneous Leishmaniasis with FDA Alignment
上个月
Adjuvia Therapeutics Raises $8 Million Seed Round to Advance Mitochondrial Therapy ATI-105 Toward Clinical Trials
2年前
Aclaris Therapeutics Initiates Phase IIa Trial of ATI-2138 for Atopic Dermatitis
去年
Appili Therapeutics Gains FDA Alignment on ATI-1801 for Cutaneous Leishmaniasis
去年
Appili Therapeutics Gains FDA Alignment on ATI-1801 Development for Leishmaniasis
去年
Appili Therapeutics Receives Positive FDA Feedback on ATI-1801 Development for NDA Submission
去年
First-in-Human HIV Vaccine Induces Virus-Specific Neutralizing Antibodies
去年
Appili Therapeutics Advances Pipeline with FDA-Approved Drug Launch and Vaccine Progress
第 1 页,共 418 页
上一页
下一页